Publications by authors named "Jacob Aday"

Claim this Profile
D
Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.
Mallet R Reid, Jonathan Song, Kevin F Boehnke, NiCole T Buchanan, Jacob S Aday

Neurosci Biobehav Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.
Nicolas G Glynos, Anne Baker, Jacob S Aday, Niloufar Pouyan, Julie Barron

J Psychoactive Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Psychedelic Use and Positive Adult Development in Emerging Adulthood: An Integrative Review.
Jake Payne, Oliver Robinson, Kevin St Arnaud, Jacob S Aday, Melissa Warner

Brain Behav· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.
Daniel J Kruger, Gina Mersereau, Ashley Sullivan, Julie Barron, Moss Herberholz, Jacob S Aday

Harm Reduct J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans.
Leehe Peled-Avron, Jacob S Aday, Madeline M Pantoni, Holly K Hamilton, Joshua D Woolley

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.
Jacob S Aday, Emily K Bloesch, Alan K Davis, Sarah E Domoff, Kyle Scherr

J Psychoactive Drugs· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments.
Niloufar Pouyan, Jacob S Aday, Steven E Harte, Chelsea M Kaplan, David A Williams

J Psychopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing blinding in classic psychedelic studies with innovative active placebos.
Jacob S Aday, Otto Simonsson, Emmanuelle A D Schindler, Deepak Cyril D'Souza

Int J Neuropsychopharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Differences in Naturalistic Psychedelic Use - Motivations for Use, Communication with Health Care Providers, and Outcomes.
Nicolas G Glynos, Mallet R Reid, Jacob S Aday, Daniel J Kruger, Kevin F Boehnke

J Psychoactive Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation.
Daniel J Kruger, Eirini K Argyri, Justin K Mogilski, Moss Herberholz, Julie Barron, Jacob S Aday

J Sex Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial.
Jacob S Aday, Jenna McAfee, Deirdre A Conroy, Avinash Hosanagar, Vijay Tarnal

Front Pain Res (Lausanne)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users.
Daniel J Kruger, Jacob S Aday, Christopher W Fields, Nicholas Kolbman, Nicolas Glynos

Psychedelic Med (New Rochelle)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use.
Daniel J Kruger, Jeff Albrecht, Jacob S Aday, Julie Barron, Moss Herberholz

J Psychoactive Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.
Nicolas G Glynos, Anne Baker, Jacob S Aday, Daniel Kruger, Kevin F Boehnke

Br J Pain· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S Aday, David Horton, Gisele Fernandes-Osterhold, Aoife O'Donovan, Ellen R Bradley

Psychopharmacology (Berl)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Down the rabbit hole - the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions.
Leehe Peled-Avron, Jacob S Aday, Amilia Lydia Kalafateli, Holly K Hamilton, Joshua D Woolley

Front Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field.
Jacob S Aday, Natasha L Mason, Bo Jarrett Wood, Hannah M Kramer, Cynthia E Ortiz

Psychedelic Med (New Rochelle)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.
Nicolas G Glynos, Jacob S Aday, Daniel Kruger, Kevin F Boehnke, Stephanie Lake

Front Psychiatry· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.
L Jacob Flameling, Jacob S Aday, Michiel van Elk

ACS Chem Neurosci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.
Jacob S Aday, Brian S Barnett, Dan Grossman, Kevin S Murnane, Charles D Nichols

Psychedelic Med (New Rochelle)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Challenges for Psychedelic Therapy.
Jacob S Aday, Robin L Carhart-Harris, Joshua D Woolley

JAMA Psychiatry· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces.
Jacob S Aday, Lin Fang, Joshua M Carlson

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.
Jacob S Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet

Psychedelic Med (New Rochelle)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.
Jacob S Aday, Boris D Heifets, Steven D Pratscher, Ellen Bradley, Raymond Rosen

Psychopharmacology (Berl)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.
Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt

J Psychopharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis